CytomX Therapeutics
CTMX
CTMX
122 hedge funds and large institutions have $698M invested in CytomX Therapeutics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 55 increasing their positions, 31 reducing their positions, and 34 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
55% less call options, than puts
Call options by funds: $724K | Put options by funds: $1.62M
59% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 34
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
Holders
122
Holding in Top 10
1
Calls
$724K
Puts
$1.62M
Top Buyers
| 1 | +$21.6M | |
| 2 | +$16.7M | |
| 3 | +$15.5M | |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
+$14.3M |
| 5 |
PA
Perceptive Advisors
New York
|
+$13.7M |
Top Sellers
| 1 | -$6.92M | |
| 2 | -$6.87M | |
| 3 | -$6M | |
| 4 |
Man Group
London,
United Kingdom
|
-$3.43M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$1.88M |